Arkolith/Insider Trading/VXRT/Form 4

Cummings James F.

Chief Medical OfficerVaxart, Inc. (VXRT) · full profile →Form 4 · filed Mar 26, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 24, 2025Grant(A)406K—$0749K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 24, 2025Grant(A)610K—$0610K
Mar 24, 2025Grant(A)50K—$050K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-009448) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML